# Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.

> **NCT00150813** · PHASE3 · COMPLETED · sponsor: **UCB Pharma SA** · enrollment: 66 (actual)

## Conditions studied

- Epilepsy, Tonic-clonic

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT00150813
- **Lead sponsor:** UCB Pharma SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08-10
- **Primary completion:** 2007-05-29
- **Final completion:** 2007-05-29
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2018-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00150813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00150813, "Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00150813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*